De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer

NCT07421141 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2-positive Breast Cancer
Early Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: trastuzumab
DRUG: Pertuzumab
DRUG: Docetaxel
DRUG: carboplatin
PROCEDURE: Radical Surgery
DRUG: Adjuvant Systemic Therapy

Sponsor

National Medical Research Radiological Centre of the Ministry of Health of Russia